Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2017	Mar. 31, 2016
Assets
Cash and cash equivalents	$ 17,307	$ 15,542
Accounts receivable, net	9,171	10,889
Inventories, net	13,593	17,024
Deferred contract costs	935	37
Prepaid expenses and other current assets	2,877	5,038
Total current assets	43,883	48,530
Property and equipment, net	13,786	17,004
Other intangible assets, net	4,207	5,048
Long-term accounts receivable	5	108
Other long-term assets	170	185
Total assets	62,051	70,875
Liabilities and Shareholders’ Equity
Accounts payable	11,635	11,716
Accrued expenses and other	5,988	6,586
Deferred revenue, current	621	243
Current maturities of long-term debt	152	746
Total current liabilities	18,396	19,291
Revolving credit facility	6,629	3,719
Long-term debt, less current maturities	190	302
Deferred revenue, long-term	944	1,022
Other long-term liabilities	442	558
Total liabilities	26,601	24,892
Commitments and contingencies
Shareholders’ equity:
Preferred stock, $0.01 par value: Shares authorized: 30,000,000 shares at March 31, 2017 and 2016; no shares issued and outstanding at March 31, 2017 and 2016	0	0
Common stock, no par value: Shares authorized: 200,000,000 at March 31, 2017 and 2016; shares issued: 37,747,227 and 37,192,559 at March 31, 2017 and 2016; shares outstanding: 28,317,490 and 27,767,138 at March 31, 2017 and 2016	0	0
Additional paid-in capital	153,901	152,140
Treasury stock: 9,429,737 and 9,425,421 common shares at March 31, 2017 and 2016	(36,081)	(36,075)
Shareholder notes receivable	(4)	(4)
Retained deficit	(82,366)	(70,078)
Total shareholders’ equity	35,450	45,983
Total liabilities and shareholders’ equity	$ 62,051	$ 70,875